BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs7903146
,
PBX1
,
nitric oxide metabolic process
,
Lung cancer
,
Kidney
,
Avian flu virus
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
fibroblast growth factor- 2
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Non-small cell lung cancer HCC515 cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
L1000 CMAP - Carcinoma of prostate PC3 cells treated with ligand perturbagens
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Improved Production of Anti-FGF-2 Nanobody Using Pichia pastoris and Its Effect on Antiproliferation…
Disulfide bridge-dependent dimerization triggers FGF2 membrane translocation into the extracellular …
Scleral remodeling in early adulthood: the role of FGF-2.
Fibroblast growth factor 2 (FGF2) ameliorates the coagulation abnormalities in sepsis.
The effect of fibroblast growth factor-2 on the outcomes of tooth replantation: A systematic review …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Recombinant Human Fibroblast Growth Factor-2 (rhFGF-2) In Gingival Recession Defects
Trial in Periodontal Tissue Regeneration Using Fibroblast Growth Factor-2
Phase I, Dose-escalation Trial of BAY1187982 in Subjects With Advanced Solid Tumors Known to Express…
Phase 3 Clinical Trial of Periodontal Tissue Regeneration Using Fibroblast Growth Factor-2(Trafermin…
A Study to Assess the Safety of Using Fibroblast Growth Factor-2 With Periodontal Surgery in Japan (…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ